Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy
Karin Zattar Cecyn1, Mariana Oliveira Marques1, Milena Almendra Rodrigues1, Fábio Nascimento Brito2, Otávio Cesar Carvalho Guimarães Baiocchi1
1Departamento de Oncologia Clínica e Experimental, Universidade Federal de São Paulo – UNIFESP,
2Departamento de Hematologia-Hemoterapia, Hospital Santa Marcelina, Sao Paulo, Brazil
Correspondence to: Karin Cecyn, Ph.D.
Departamento de Oncologia Clínica e Experimental, Universidade Federal de São Paulo – UNIFESP, Rua Dr. Diogo de Faria, 824, Sao Paulo - CEP 04037-002, Brazil
E-mail: kcecyn@gmail.com
Published online: August 12, 2021.
© The Korean Journal of Hematology. All rights reserved.



e-submission

This Article

Current Issue

ba_link01

SCImago Journal & Country Rank

Indexed/Covered by

Today : 72  /
Total : 335,504